Atlas Trials

Phase II Clinical Clical of the Pure Protein Derivatives of BCG

Clinical trial NCT06975774 · COMPLETED

Trial details

NCT number
NCT06975774
Sponsor
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Tuberculosis
Start date
2023-07-26
Primary completion
2023-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.